Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Biemond

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|July 10, 2023
Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell diseaseE Dovern, B J Biemond, E Nur
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2005
[Pathophysiology and treatment of sickle-cell disease]E J van Beers, M Peters, B J Biemond
Nederlands Tijdschrift Voor Geneeskunde|September 8, 2007
[From gene to disease; JAK2 and polycythaemia vera]H R Koene, B J Biemond, C E van der Schoot
Thrombosis and Haemostasis|August 1, 1991
Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis modelM Levi, B J Biemond, A Sturk, et al.
Circulation|January 1, 1992
Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosisM Levi, B J Biemond, A J van Zonneveld, et al.
Thrombosis and Haemostasis|September 1, 1994
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis modelB J Biemond, M Levi, M T Nurmohamed, et al.
Circulation|February 15, 1995
Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibodyB J Biemond, M Levi, R Coronel, et al.
Thrombosis and Haemostasis|October 1, 1996
Inactivation of factor Xia in vivo: studies in chimpanzees and in humansW A Wuillemin, C E Hack, W K Bleeker, et al.
Circulation|January 1, 1996
Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosisB J Biemond, P W Friederich, M Levi, et al.
The Netherlands Journal of Medicine|June 27, 2013
Chest pain in sickle cell diseaseS H Tonino, E Nur, H M Otten, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|July 10, 2023
Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell diseaseE Dovern, B J Biemond, E Nur
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2005
[Pathophysiology and treatment of sickle-cell disease]E J van Beers, M Peters, B J Biemond
Nederlands Tijdschrift Voor Geneeskunde|September 8, 2007
[From gene to disease; JAK2 and polycythaemia vera]H R Koene, B J Biemond, C E van der Schoot
Thrombosis and Haemostasis|August 1, 1991
Variable effects of radiological contrast media on thrombus growth in a rabbit jugular vein thrombosis modelM Levi, B J Biemond, A Sturk, et al.
Circulation|January 1, 1992
Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosisM Levi, B J Biemond, A J van Zonneveld, et al.
Thrombosis and Haemostasis|September 1, 1994
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis modelB J Biemond, M Levi, M T Nurmohamed, et al.
Circulation|February 15, 1995
Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibodyB J Biemond, M Levi, R Coronel, et al.
Thrombosis and Haemostasis|October 1, 1996
Inactivation of factor Xia in vivo: studies in chimpanzees and in humansW A Wuillemin, C E Hack, W K Bleeker, et al.
Circulation|January 1, 1996
Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosisB J Biemond, P W Friederich, M Levi, et al.
The Netherlands Journal of Medicine|June 27, 2013
Chest pain in sickle cell diseaseS H Tonino, E Nur, H M Otten, et al.
Pageof 5